Princess Marina Hospital
Bontleng, Gaborone, Botswana
Location contact
Bame Bame
CONTACT
Chelsea Morroni, MBChB, DFSRH, DTMH, MPhil, MP
CONTACT
NCT Number: NCT07597824
This study evaluates strategies to improve access to HIV prevention through the integration of pre-exposure prophylaxis (PrEP) into existing healthcare settings, rather than limiting delivery to specialty clinics. The study addresses barriers to PrEP uptake, including limited awareness, stigma, and restricted access, and recognizes that availability alone may not ensure initiation or sustained use.
The study includes two components. First, a longitudinal cohort of current PrEP users will be followed to assess changes in access, preferences, and PrEP use over time in real-world settings. Second, a dynamic decision-support toolkit will be developed and evaluated to support patients and providers in PrEP-related decision-making. The toolkit will include patient- and provider-facing components to support clinical decision-making, improve risk understanding, and facilitate integration of PrEP into routine healthcare. The toolkit will be refined and beta-tested in selected healthcare facilities in Botswana and Alabama.
Trial opening soon.
Get Notified18 year and older
All sexes
Observational
Bontleng, Gaborone, Botswana
Bame Bame
CONTACT
Chelsea Morroni, MBChB, DFSRH, DTMH, MPhil, MP
CONTACT
Pre-exposure prophylaxis (PrEP) is an evidence-based and effective approach to HIV prevention, yet it has not reached its full potential due to factors such as limited awareness, constrained service resources, and stigma. Currently, most PrEP prescriptions are issued in specialty care settings, offering limited access. Therefore, achieving global implementation goals will require expanding PrEP delivery within other existing health facilities.
Making PrEP available in existing outpatient or inpatient settings alone does not guarantee its initiation or sustained use, even among individuals at risk for HIV acquisition. Appropriate decision-making regarding PrEP use requires collaboration between patients and providers, supported by an enabling clinic infrastructure. Moreover, the PrEP journey can be dynamic, with more PrEP modalities becoming available in recent years, and choices can change over time, underscoring the need for decision-support toolkits that help patients and providers navigate this evolving decision-making process. A decision support toolkit that has components that are either patient- or provider-facing, or both, could enhance patients' risk perception and increase their knowledge of PrEP, enabling them to make informed decisions about its use, as well as decrease the decision-making burden on the provider side.
As such, the investigators aim to (1) propose an implementation strategy that integrates PrEP into existing health facilities and (2) develop a dynamic choice decision support toolkit that supports PrEP integration into these existing health facilities.
Thus, our specific aims are:
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Group 1
Group 2
Group 3
No intervention
Time frame: Up to 2 years
Among participants who initiate PrEP, to determine the proportion who continue PrEP use over 2 years.
Time frame: Within 2 years after the initial PrEP clinic visit
To determine the number and proportion of participants in the PrEP clinic who initiate PrEP.
Time frame: Up to 2 years
Among participants who initiate PrEP, to determine the number and proportion who switch between PrEP modalities.
Time frame: Up to 2 years
Among participants who initiate PrEP, to determine the number and proportion who discontinue PrEP.
Contact information is provided by the study sponsor or research team.
University of Alabama at Birmingham
Other
Acronym: DYNAMIC PrEP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07516548
Blood-Borne Infections, Communicable Diseases
Bontleng, Gaborone, Botswana
View Trial DetailsNCT05044962
Blood-Borne Infections, Communicable Diseases
Eldoret, Kenya
View Trial DetailsNCT04666792
Blood-Borne Infections, Communicable Diseases
Kisumu, Kenya
View Trial DetailsNCT04669678
Blood-Borne Infections, Communicable Diseases
Johannesburg, South Africa
View Trial Details